• Tidak ada hasil yang ditemukan

BAB V SIMPULAN DAN SARAN

5.2 Saran

1. Dilakukan penelitian lebih lanjut untuk menilai pengaruh faktor sosial ekonomi dan kondisi psikologis.

2. Dilakukan pemeriksaan obyektif dari sensitivitas kontras, glare dan stereoaakuitas untuk melihat pengaruhnya terhadap kualitas hidup penderita glaukoma selain penurunan lapang pandang.

3. Penggunaan performance-based test dapat dipertimbangkan dalam memberikan representasi yang lebih obyektif terkait dampak dari penurunan lapang pandang pada kegiatan sehari-hari penderita glaukoma

4. Lokasi kelainan lapang pandang pada area tertentu mungkin dapat lebih mempengaruhi penurunan kualitas hidup dibandingkan area lainnya. Hal ini dapat menjadi subyek untuk diteliti pada penelitian selanjutnya.

67

DAFTAR PUSTAKA

1. Saunders, L. J., Medeiros, F. A dkk. What rates of glaucoma progression are clinically significant? Expert Review of Ophthalmology. 2016;11(3):

227–234

2. Ichhpujani P. Kumar S. What’s New in Pathogenesis of Glaucoma. In:

Glaucoma. First Edition. Singapore: Springer;2019: p.1-2

3. Tham, Y.C., Li, X dkk. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophthalmology. 2014; 121(11): 2081–

2090.

4. Balantrapu T. Latest Global Blindness & Visual Impairment prevalence figures published in Lancet [document on the Internet]. IAPB; 2017 [cited 2020 January]. Diunduh dari: http:/ https://www.iapb.org/news/latest- global-blindness-vi-prevalence-figures-published-lancet/

5. Pascolini, D., & Mariotti, S. P. Global estimates of visual impairment: 2010.

British Journal of Ophthalmology.2011; 96(5): 614–618.

6. Pusat Data dan Informasi Kementerian Kesehatan RI. Situasi dan analisis Glaukoma. Jakarta: Pusat Data dan Informasi Kementerian Kesehatan RI;

2015.

7. European Glaucoma Society. Terminology and guidelines for glaucoma.

4thed. Savona, Italy: DOGMA; 2014.

8. Quaranta, L., Riva, I. dkk. Quality of Life in Glaucoma: A Review of the Literature. Advances in Therapy. 2016; 33(6);959–81.

9. Mangione CM, Lee PP, Gutierrez PR, et al; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25- item National Eye Institute visual function questionnaire. Arch Ophthalmol 2001;119(7):1050–8

10. Kumar, S., Thakur S, Ichhpujani P. The impact of primary open-angle glaucoma: Comparison of vision-specific (National Eye Institute Visual Function Questionnaire-25) and disease-specific (Glaucoma Quality of Life-15 and Viswanathan 10) patient-reported outcome (PRO) instruments.

Indian J Ophthalmol. 2019; 67(1): 83–88.

11. Heijl A; Vincent M P; Bengtsson B. Effective Perimetry. Fourth Edition.

Dublin, CA : Carl Zeiss Meditec Inc.; 2012:pp.1-22, 45-72

12. Shaarawy TM, Sherwood MB, dkk. Glaucoma Medical Diagnosis and Therapy. Second Edition. Philadelphia: Elsevier; 2015: pp.128-9, 272-3, 510-9

13. Bengtsson, B., & Heijl, A. A Visual Field Index for Calculation of Glaucoma Rate of Progression. American Journal of Ophthalmology.2008;

145(2): 343–353.

14. Peters, D., Heijl, A., Brenner, L., & Bengtsson, B. Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up. Acta Ophthalmologica.2015;93(8); 745–752

15. Rosalina D, Harijo W. Visual Field Abnormality and Quality of Life of Patient with Primary Open Angle Glaucoma. Jurnal Oftalmologi Indonesia.

2011; 7(5): 175−180

16. Sawada, H., Fukuchi, T., & Abe, H. Evaluation of the relationship between quality of vision and the visual function index in Japanese glaucoma patients. Graefe’s Archive for Clinical and Experimental Ophthalmology.2011; 249(11): 1721–1727

17. McKean-Cowdin R, Wang Y dkk. Impact of Visual Field Loss on Health- Related Quality of Life in Glaucoma. The Los Angeles Latino Eye Study.

Ophthalmology.2008; 115:941–48

18. Nelson, P., Aspinall, P. dkk. Quality of Life in Glaucoma and Its Relationship with Visual Function. Journal of Glaucoma. 2003;12(2): 139–

50.

19. Seymour JR. Yee T dkk. Visual Fields in Glaucoma [document on the Internet]. Ento Key; 2016 Jul 11 [diunduh 10 Januari 2020]. Tersedia dari:

https://entokey.com/visual-fields-in-glaucoma/

20. Reynolds AC. Computerized Assessment of Visual Field Progression.

[Internet] [cited 2020 January 17]. Diunduh dari: https:

http://glaucomatoday.com/2011/08/computerized-assessment-of-visual- field-progression/

21. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychological Medicine,1998: 28(3): 551–58

22. Burckhardt CS1, Anderson KL. The Quality of Life Scale (QOLS):

reliability, validity, and utilization. Health Qual Life Outcomes. 2003 Oct;

23(1):60.

23. Pourjavan S. A Spratt. A Kotecha. Patient reported outcomes in glaucoma:

associations between the NEI VFQ‐25 and the GQL‐15 and clinical measures of visual function. Acta Ophtalmologica [abstract]. 2010 [diunduh

17 Januari 2020]. Tersedia dari:

https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1755-3768.2010.4356.x 24. Vandenbroeck, S., De Geest, S., Zeyen, T dkk. Patient-reported outcomes

(PRO’s) in glaucoma: a systematic review. Eye. 2011; 25(5): 555–577 25. Realini T. The Visual Field Index. [Internet] [cited 2020 January 17].

Diunduh dari https://www.eyeworld.org/article-the-visual-field

26. Severn, P., Fraser, S., Finch, T., & May, C. Which quality of life score is best for glaucoma patients and why? BMC Ophthalmology.2008; 8(1) 27. Lee BL, Gutierrez P, Gordon M, et al. The Glaucoma Symptom Scale. A

brief index of glaucoma-specific symptoms. Arch Ophthalmol 1998;116(7):861–6.

28. Noe G, Ferraro J, Lamoureux E, et al. Associations between glaucomatous visual field loss and participation in activities of daily living. Clin Exp Ophthalmol 2003;31(6):482–6.

29. Nelson, P., Aspinall, P., & O’Brien, C. Patients’ perception of visual impairment in glaucoma: a pilot study. British Journal of Ophthalmology.1999;83(5): 546–52.

30. Lamoureux, E., & Pesudovs, K. Vision-Specific Quality-of-Life Research:

A Need to Improve the Quality. American Journal of Ophthalmology.

2011;151(2): 195–7

31. Leske MC, Heijl A, Hyman L, Bengtsson B. Early manifest glaucoma trial:

design and baseline data. Ophthalmology. 1999;106:2144–53.

32. Gedde SJ, Schiffman JC, Feuer WJ, et al. The tube versus trabeculectomy study: design and baseline characteristics of study patients. Am J Ophthalmol. 2005;140:275–87.

33. Mills, R. P., Janz, N. K., Wren, P. A., & Guire, K. E. (2001). Correlation of Visual Field With Quality-of-Life Measures at Diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Journal of Glaucoma, 10(3), 192–198.

34. Janz, N. The Collaborative Initial Glaucoma Treatment Study Interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology.2001; 108(11): 1954–1965.

35. National Eye Institute. Visual Function Questionnaire-25. [Internet]. 2000 [cited 2020 January 10]. Diunduh dari: https://www.nei.nih.gov/learn- about-eye-health/resources-for-health-educators/outreach-materials/visual- function-questionnaire-25

36. Riva, I., Legramandi, L., dkk. Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients. Scientific Reports. 2019;9(1)

37. Sukumar, S., Spencer, F., Fenerty, C., Harper, R., & Henson, D. (2008). The influence of socioeconomic and clinical factors upon the presenting visual field status of patients with glaucoma. Eye, 23(5), 1038–1044.

38. Buys, Y. M., & Jin, Y.-P. (2013). Socioeconomic status as a risk factor for late presentation of glaucoma in Canada. Canadian Journal of Ophthalmology / Journal Canadien d’Ophtalmologie, 48(2), 83–87

39. Lisboa, R., Chun, Y. S. dkk. Association Between Rates of Binocular Visual Field Loss and Vision-Related Quality of Life in Patients With Glaucoma.

JAMA Ophthalmology. 2013;131(4): 486.

40. Ko YC., Hwang, DK dkk. Impact of Socioeconomic Status on the Diagnosis of Primary Open-Angle Glaucoma and Primary Angle Closure Glaucoma:

A Nationwide Population-Based Study in Taiwan. PLOS ONE. 2016;11(2) 41. Hyman, L. G., Komaroff, E. dkk. Treatment and Vision-Related Quality of Life in the Early Manifest Glaucoma Trial. Ophthalmology.2005; 112(9):

1505–13.

42. Yousefi, S., Sakai, H dkk. Asymmetric Patterns of Visual Field Defect in Primary Open-Angle and Primary Angle-Closure Glaucoma. Investigative Opthalmology & Visual Science.2018; 59(3): 1279.

43. Cheng, HC., Guo, CY dkk. Patient-Reported Vision-Related Quality of Life Differences Between Superior and Inferior Hemifield Visual Field Defects in Primary Open-Angle Glaucoma. JAMA Ophthalmology.

2015;133(3): 269.

44. Rao A. Comparison of relation between visual function index and retinal nerve fiber layer structure by optical coherence tomography among primary open angle glaucoma and primary angle closure glaucoma eyes. Oman

Journal of Ophthalmology.2014;7(1)

45. Boland, M. V., Zhang, L dkk. Comparison of Optic Nerve Head Topography and Visual Field in Eyes with Open-angle and Angle-closure Glaucoma. American Academy of Ophthalmology. 2008;115:239–245 46. Skalicky, S. E., Martin, K. R, dkk. Cataract and quality of life in patients

with glaucoma. Clinical & Experimental Ophthalmology. 2014;43(4), 335–

41.

47. Gutierrez P., Wilson M.R., Johnson C., et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997;115(6):777–84.

48. Madonna R.J., D. Rutner, L. Nehmad. Investigating the Association between Visual Field Index Scores and NEI VFQ-25 Scores in Glaucoma Patients. Investigative Ophthalmology & Visual Science [abstract].

2019;50:3771 [diunduh 17 Januari 2020]. Tersedia dari:

https://iovs.arvojournals.org/article.aspx?articleid=2366157

49. Evans K.,Simon K.L., dkk. The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration. Clinical Ophthalmology. 2009;3: 433–45

50. Field, A. Discovering Statistics Using SPSS. London : SAGE Publication Ltd; 2011

51. Sopiyudin D. Statistik untuk kedokteran dan kesehatan. Edisi ke-5. Salemba Medika;2010.

52. Sudigdo S. Dasar-dasar metodologi Penelitian Klinis. Edisi ke-4, Sagung Seto; 2011

53. American Academy of Ophthalmology. Section 10: Glaucoma:

Introduction to Glaucoma: Terminology, Epidemiology, and Heredity. In : Basic and Clinical Science Course. San Fransisco: American Academy of Ophtalmology; 2019.

54. Medeiros, F. A., Gracitelli, C. P. B., et al. Longitudinal Changes in Quality of Life and Rates of Progressive Visual Field Loss in Glaucoma Patients.

Ophthalmology,2015;122(2):293–301.

55. Sawada H, Fukuchi, T., & Haruki, A. Evaluation of the relationship between quality of vision and visual function in Japanese glaucoma patients. Clinical Ophthalmology, Clinical Ophthalmology 2011:5:259–67

56. Kuo, Y.S., Liu, C. J, et al. Impact of socioeconomic status on vision-related quality of life in primary open-angle glaucoma. Eye.2017;31(10):1480–7.

57. Chun, Y. S., Sung, K. R., Park, C. K., et al. Factors influencing vision- related quality of life according to glaucoma severity. Acta Ophthalmologica. 2019;97(2):216-24

58. Sawada, H., Yoshino, T., Fukuchi, T., & Abe, H. Assessment of the Vision- specific Quality of Life Using Clustered Visual Field in Glaucoma Patients.

Journal of Glaucoma, 2014;23(2): 81–7.

59. McKean-Cowdin, R., Varma, R., et al. Severity of Visual Field Loss and Health-related Quality of Life. American Journal of Ophthalmology, 2007;143(6): 1013–23.

60. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface

disease in glaucoma patients. J Glaucoma. 2008;17:350–5

61. Rossi GC, Pasinetti GM, Scudeller L, et al. Ocular surface disease and glaucoma: how to evaluate impact on quality of life. J Ocul Pharmacol Ther. 2013;29:390–4.

62. Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol 2007;144(2):238-44.

63. Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma.

2008;17:552–7.

64. Freeman EE, Munoz B, West SK, Jampel HD, Friedman DS. Glaucoma and quality of life: the Salisbury eye evaluation. Ophthalmology.

2008;115:233–8.

65. Freeman EE, Munoz B, Turano KA, West SK. Measures of visual function and their association with driving modification in older adults. Invest Ophthalmol Vis Sci. 2006;47:514–20.

66. Wood JM, Black AA, Mallon K, et al. Glaucoma and Driving: On-Road Driving Characteristics. PLoS ONE.2016;11(7):1-12

67. Haymes SA, LeBlanc RP, Nicolela MT, et al. Glaucoma and On-Road Driving Performance. Invest Ophthalmol Vis Sci. 2008;49: 3035–3041

LAMPIRAN 1. PERSETUJUAN ETIK

LAMPIRAN 2. INFORMED CONSENT

LAMPIRAN 3. KUESIONER NEI-VFQ-25 BAHASA INDONESIA

LAMPIRAN 4. MANUAL SCORING SUBSKALA KUESIONER NEI-VFQ-25

LAMPIRAN 5. DATA PENELITIAN

KETERANGAN:

Pekerjaan 1.Tidak Bekerja 2.Sekolah/Mahasiswa 3.Buruh

4.Pegawai 5.Wiraswasta 6.POLRI/TNI 7.Profesional

8.Lainnya

Pendapatan 1. < Rp1.500.000

2. Rp1.500.000- <2.500.000 3. Rp.2.500.000 – Rp.3.500.000 4. >Rp. 3.500.000

Pendidikan 1.Rendah (tidak sekolah, SD,atau MI)

2.Sedang (SMP,SMA,SMK,MK,MAK)

3.Tinggi

(Dipl,Sarjana,Magister,Spesialis,Doktor)

LAMPIRAN 6. ANALISIS STATISTIK

LAMPIRAN 7 DAFTAR RIWAYAT HIDUP

Nama : Fatrin Patrycia Salim

Tempat/Tanggal Lahir : Palembang, 7 Mei 1987 Alamat : Jl. Surya Widuri IV, Jakarta.

Nama Orang Tua : Johannes Sadariman Agnes Widyakusuma Pendidikan Formal

1. SD Ricci II (1993-1999) 2. SLTP Ricci II (1999-2002) 3. SMU St.Laurensia (2002-2005)

4. Fakultas Kedokteran Universitas Pelita Harapan (2005-2011) 5. Program Pendidikan Dokter Spesialis-1 Ilmu Kesehatan Mata FK

Universitas Padjadjaran/PMN-RS Mata Cicendo Bandung (2016-2020) Pengalaman Kerja

1. 2011 - 2013  Staf pengajar (Tutorial) Fakultas Kedokteran Universitas Pelita Harapan

 Dokter magang Poliklinik Mata Siloam Hospital Lippo Village 2. 2013 - 2015 Dokter umum RS Umum Siloam 3. 2015 - 2016 Outpatient Case Manager RS

Umum Siloam Penelitian :

1. 2018 Effect of Panretinal

Photocoagulation on Color Vision in Diabetic Retinopathy.

2. 2019 Tajam Penglihatan dan Komplikasi Pasca Implantasi Lensa Intraokular Sekunder.

Presentasi Ilmiah

1. Paper Presentation, topic : “Tobacco-Its burden on Health and Society” Asian Medical Student Conference (AMSC) International - Hongkong (2006)

2. Poster Presentation: Retropupillary Iris Claw as Management of Low Corneal Endothelial Aphakia - PIT PERDAMI 43, Padang (2018) 3. Free paper: Visual Acuity And Complications Following Secondary

Intraocular Lens Implantation In Aphakia - PIT PERDAMI 44, Makassar (2019)

4. Free paper: Effect of Panretinal Photocoagulation Laser on Color Vision in Diabetic Retinopathy - PIT PERDAMI 44, Makassar (2019)

Seminar/Course/Kongres/Pertemuan Ilmiah yang pernah diikuti

1. 2005 Advanced English Skills (AES)

oleh Lembaga International Language Programs

2. 2006 Paper and Presentation

Training oleh AMSA (Asian Medical Student Association) Indonesia

3. 2011  Peserta Advance Cardiac Life

Support Training, PERKI, Jakarta

 Peserta PIT PERDAMI ke-37, Manado

 Peserta workshop Interpreting Visual Field Defects, Manado

4. 2012  Peserta simposium “Highlights

in Ophtalmology” by Dutch Foundation -Universitas Indonesia

 Peserta simposium “West Java Region IOA Scientific Meeting”, Bandung

 Peserta workshop “Streak Retinoscopy” Universitas Padjajaran, Bandung

 Peserta simposium Annual Scientific Meeting – “Adaptasi Kesehatan terhadap Perubahan Iklim” Universitas Gadjah Mada, Yogyakarta

 Peserta simposium “Focus on Diabetic Retinopathy – from screening to managing complications” Universitas Indonesia Jakarta

 Peserta PIT PERDAMI ke-38, Surabaya

5. 2013 Four-weeks Clinical Elective Program di Schell Eye Hospital, Tamil Nadu, India

6. 2014  Peserta PIT PERDAMI ke-39

Jawa Tengah, Yogyakarta

7. 2015  Peserta Young Ophtalmologist

Program (YOP) oleh PERDAMI Banten

 Peserta PIT PERDAMI ke-40 Jawa Barat, Bandung

8. 2018  Peserta PIT PERDAMI ke 43

Sumatera Barat, Padang

9. 2019  Peserta INOIS 7th PERDAMI

Jawa Tengah, Yogyakarta

 Peserta PIT PERDAMI ke-44, Sulawesi Selatan, Makassar

 Peserta Cicendo International Ophtalmology Meeting, Bandung

Pengalaman Organisasi

1. 2005 – 2006 Wakil Ketua Asian Medical Students Association (AMSA) Universitas Pelita Harapan (UPH)

2. 2006 Koordinator Seksi Acara Simposium

Neurodegenerative Update

Dokumen terkait